Pharmaceutical News

RSS

Drug used to treat intestinal worms could protect people from periodontitis, says study

A drug currently used to treat intestinal worms could protect people from periodontitis, an advanced gum disease, which untreated can erode the structures-including bone-that hold the teeth in the jaw. The research was published ahead of print in Antimicrobial Agents and Chemotherapy.

11 Nov 2013

Adequate vitamin D levels vital for maintaining the health of kidney transplant recipients

Adequate vitamin D levels are important for maintaining kidney transplant recipients' health, according to a study that will be presented at ASN Kidney Week 2013 November 5-10 at the Georgia World Congress Center in Atlanta, GA.

10 Nov 2013

First generic versions of Aciphex delayed-release tablets get FDA approval for GERD treatment

The U.S. Food and Drug Administration today approved the first generic versions of Aciphex (rabeprazole sodium) delayed-release tablets, used to treat gastroesophageal reflux disease in adults and adolescents (ages 12 and up).

10 Nov 2013

Aptiom receives FDA approval to treat seizures associated with epilepsy

The U.S. Food and Drug Administration today approved Aptiom (eslicarbazepine acetate) as an add-on medication to treat seizures associated with epilepsy.

10 Nov 2013

Patrys gets second US patent for anti-cancer product PAT-LM1

Patrys Limited, a clinical stage biotechnology company is pleased to advise that it has been granted a second US patent for lead anti-cancer product PAT-LM1.

8 Nov 2013

Breast cancer drug appears to protect cells against UV radiation, inflammation

Exemestane, a synthetic steroid drug widely prescribed to fight breast cancers that thrive on estrogens, not only inhibits the production of the hormone, but also appears to protect cells throughout the body against damage induced by UV radiation, inflammation and other assaults, according to results of research by Johns Hopkins scientists.

8 Nov 2013

Drug formulation services for highly potent active pharmaceutical ingredients provided by Evonik

Evonik Industries has broadened its capabilities in finished drug product formulation and clinical supply manufacturing and can now handle drug products containing highly potent active pharmaceutical ingredients (HPAPIs) in Darmstadt, Germany, and Birmingham, Alabama/USA. Investments in high containment facilities and upgrades in the laboratory and GMP areas in Birmingham enable Evonik to handle HPAPIs with occupational exposure limits (OEL) as low as 0.1μg/m3 and in Darmstadt as low as 1 μg/m3. Starting 2014, OEL as low as 0.1μg/m3 will also be possible in Darmstadt.

8 Nov 2013

Amneal to launch AB-rated generic for Loestrin 24 Fe

Amneal Pharmaceuticals LLC will launch its AB-rated generic for Loestrin 24 Fe (norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets) 1 mg/20 mcg, 75 mg the first week of January 2014.

8 Nov 2013

GHIT Fund makes new investments in potential treatments for malaria, tuberculosis and Chagas disease

The Global Health Innovative Technology Fund, a new public health partnership that is bringing Japanese know-how and investment to the global fight against infectious diseases, announced today grants of US$5.7 million to six global partnerships working on innovative drugs and vaccines against malaria, tuberculosis and Chagas disease.

8 Nov 2013

Scientists to develop on-demand drug-delivery system for pain management in osteoarthritis patients

Scientists are reporting development of a squishy gel that when compressed - like at a painful knee joint - releases anti-inflammatory medicine. The new material could someday deliver medications when and where osteoarthritis patients need it most. Their study appears in the ACS journal Biomacromolecules.

8 Nov 2013

Allergy shots for insect stings decreases anxiety and depression

Stinging insects are everywhere making them nearly inescapable. The thought of being stung can cause depression and anxiety for the two million Americans that are allergic to their venom.

8 Nov 2013

Pregnant women who receive allergy shots may decrease baby's chance of developing allergies

Expecting mothers who suffer from allergies may want to consider another vaccination in addition to the flu shot and Tdap. A study being presented at the Annual Scientific Meeting of the American College of Allergy, Asthma and Immunology (ACAAI) found pregnant women who receive allergy shots, also known as immunotherapy, during pregnancy may decrease their baby's chance of developing allergies.

8 Nov 2013

Nanoparticles with chemotherapeutic drugs can kill drug-resistant breast cancer cells

Nanoparticles filled with chemotherapeutic drugs can kill drug-resistant breast cancer cells, according to a study published in the scientific journal Biomaterials.

8 Nov 2013

People with gelatin allergy can have reaction from flu vaccinations

Do marshmallows make your tongue swell? Gummy bears make you itchy? If you've answered yes and are allergic to gelatin, you will want to take some precautions when getting the flu shot.

8 Nov 2013

GHIT Fund grants US$5.7 million to six global partnerships working on vaccines against malaria

The Global Health Innovative Technology Fund (GHIT Fund), a new public health partnership that is bringing Japanese know-how and investment to the global fight against infectious diseases, announced today grants of US$5.7 million to six global partnerships working on innovative drugs and vaccines against malaria, tuberculosis and Chagas disease.

8 Nov 2013

Pharmaceutical News

Drug used to treat intestinal worms could protect people from periodontitis, says study

Adequate vitamin D levels vital for maintaining the health of kidney transplant recipients

First generic versions of Aciphex delayed-release tablets get FDA approval for GERD treatment

Aptiom receives FDA approval to treat seizures associated with epilepsy

Patrys gets second US patent for anti-cancer product PAT-LM1

Breast cancer drug appears to protect cells against UV radiation, inflammation

Drug formulation services for highly potent active pharmaceutical ingredients provided by Evonik

Amneal to launch AB-rated generic for Loestrin 24 Fe

GHIT Fund makes new investments in potential treatments for malaria, tuberculosis and Chagas disease

Scientists to develop on-demand drug-delivery system for pain management in osteoarthritis patients

Allergy shots for insect stings decreases anxiety and depression

Pregnant women who receive allergy shots may decrease baby's chance of developing allergies

Nanoparticles with chemotherapeutic drugs can kill drug-resistant breast cancer cells

People with gelatin allergy can have reaction from flu vaccinations

GHIT Fund grants US$5.7 million to six global partnerships working on vaccines against malaria

Vitamin D and calcium improves bone density in male veterans treated with AEDs

UC researchers receive FDA grant to study generic tacrolimus in high-risk transplant patients

Researchers identify new class of anti-inflammatory drugs may be used to treat IBD

Stroke patients treated at hospitals with neurology residency programs benefit from tPA drugs

Patrys receives FDA Orphan Medicinal Product Designation for PAT-SM6

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News